Citation Impact
Citing Papers
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Oxygen-Regulated β 2 -Adrenergic Receptor Hydroxylation by EGLN3 and Ubiquitylation by pVHL
2009 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Death from Bronchial Asthma
1988 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Trimetazidine improved Ca2+ handling in isoprenalinemediated myocardial injury of rats
2006
Adrenergic regulation of myocardial apoptosis
2000
Prospects for Cardiovascular Research
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation.
1994
Respiratory Arrest in near-Fatal Asthma
1991 Standout
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Mitochondrial abnormalities in myocardium of dogs with chronic heart failure
1992
Parasympathetic muscarinic stimulation limits noradrenaline induced myocardial creatine kinase release: A study in the isolated perfused working rat heart
1994
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
2001 Standout
The challenge of cardiomyopathy
1989
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
The Third Intracellular Loop and the Carboxyl Terminus of β2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor
2003 StandoutNobel
Protecting the myocardium: A role for the β2 adrenergic receptor in the heart
2004 StandoutNobel
Myocardial Reperfusion Injury
2007 Standout
Hydrogen sulphide and its therapeutic potential
2007 Standout
Differential Distribution of β-Adrenergic Receptor Subtypes in Blood Vessels of Knockout Mice Lacking β1-or β2-Adrenergic Receptors
2001 StandoutNobel
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol
2004
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2Double Knockout Mice
2000 StandoutNobel
Apoptosis in the Failing Human Heart
1997 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Rationale for beta-adrenergic blocking drugs in cardiomyopathy
1985
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: Relation to pathogenesis of catecholamine cardiomyopathy
1981
The Progression From Hypertension to Congestive Heart Failure
1996 Standout
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.
1989
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Contribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy.
1983
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats
2000 StandoutNobel
Downregulation of myocardial beta-adrenergic receptors. Receptor subtype selectivity.
1994
Functional Consequences of Altering Myocardial Adrenergic Receptor Signaling
2000 StandoutNobel
Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
2002 StandoutNobel
Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.
1988
Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts
2001 StandoutNobel
Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
1999
Cardiac Arrhythmias during the Combined Use of β-Adrenergic Agonist Drugs and Theophylline
1986
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.
1996 StandoutNobel
β-Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from β1 and β2 Adrenoceptor Knockout Mice
2001 StandoutNobel
Myocardial ischemia-reperfusion injury in estrogen receptor-α knockout and wild-type mice
2000 StandoutNobel
Comparison of cardiac lesions induced in rats by isoproterenol and by repeated stress of restraint and water immersion with special reference to etiology of cardiomyopathy.
1980
The glucose hypothesis: Relation to acute myocardial ischaemia
1970
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
1975
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Myocardial damage from acute cerebral lesions.
1984
Ultrastructural alterations during ischemia and reperfusion in human hearts during cardiac surgery
1977
Chronic β-Adrenergic Stimulation Induces Myocardial Proinflammatory Cytokine Expression
2000
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.
1990
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2 Double Knockout Mice
2000 StandoutNobel
Calcium out of control
1984
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Differential effects of reoxygenation on intracellular calcium and isometric tension
1987 StandoutNobel
The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
2003 StandoutNobel
Catecholamines, Cardiac β-Adrenergic Receptors, and Heart Failure
2000 StandoutNobel
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1982 Standout
Isoproterenol-Induced Cardiac Hypertrophy: Modifications in Characteristics of β-Adrenergic Receptor, Adenylate Cyclase, and Ventricular Contraction*
1979
Myocardial injury following endogenous catecholamine release in rabbits
1985
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
Creatine and Creatinine Metabolism
2000 Standout
Concomitant use of beta adrenergic agonists and methylxanthines
1984
Works of Chappel Ci being referenced
An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.
1959
STUDIES ON INFARCT-LIKE MYOCARDIAL NECROSIS PRODUCED BY ISOPROTERENOL: A REVIEW.
1963